Hematologic Malignancies

Filter By:
17:46
Download from iTunes: https://itun.... Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world's largest p...
by:mdanderson | 153 views
19:19
This series of interviews with eight expert faculty is filmed on location during the 2014 American Society of Clinical Oncology (ASCO) Annual meeting, where the most current cancer data is presented and examined. Following the scientific sessions, Dr. James Epstein reviews and explores some of the most significant research findings in multiple tumo...
by:imedex | 198 views
18:36
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 186 views
10:37
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 229 views
13:32
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 184 views
18:36
Recent advances in basic and clinical research have enhanced our understanding of the underlying biological and genetic variations associated with myeloproliferat​ive neoplasms. These advances have enhanced classification and diagnosis of disease, contributed to more robust risk stratification models and identified novel targeted therapies for the o...
by:imedex | 167 views
20:50
Recent advances in basic and clinical research have enhanced our understanding of the underlying biological and genetic variations associated with myeloproliferat​ive neoplasms. These advances have enhanced classification and diagnosis of disease, contributed to more robust risk stratification models...
by:imedex | 179 views
14:28
Recent advances in basic and clinical research have enhanced our understanding of the underlying biological and genetic variations associated with myeloproliferat​ive neoplasms. These advances have enhanced classification and diagnosis of disease, contributed to more robust risk stratification models...
by:imedex | 166 views
12:25
Cutting-edge updates and expert perspectives on the diagnosis and management of hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia and related disorders, and Hodgkin's and non-Hodgkin's lymphomas were presented and discussed at the 10th European Congress on Hematologic Malignancies. Dr. Campos presents an overview of...
by:imedex | 505 views
03:33
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 787 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)